1. Anderson PO. Drug use during breast-feeding. Clin Pharm1991; 10:594-624.
2.
2. Wesson DR, Camber S, Harkey M, Smith DE. Diazepam and desmethyldiazepam in breast milk. J. Psychoactive Drugs1985; 17:55-56.
3.
3. Patrick MJ, Tilston WJ, Reavy P. Diazepam and breastfeeding. Lancet1972; 1(7749):542-543.
4.
4. Erkkola R, Kanto J. Diazepam and breastfeeding. Lancet1972; 1:1235-1236.
5.
5. Whitelaw, AGL, Cummings AJ, McFadyen, IR. Effect of maternal lorazepam on the neonate. Brit Med J1981; 282:1106-1108.
6.
6. McBride RJ, Dundee JW, Moore J, Toner W, Howard PJ. A study of the plasma concentrations of lorazepam in mother and neonate. Br J Anaesth1979; 51:971-971.
7.
7. Summerfield RJ, Nielsen MS. Excretion of lorazepam into breast milk [letter]. Br J Anaesth1985; 57(10):1042-1043.
8.
8. Matheson I, Lunde PK, Bredesen JE. Midazolam and nitrazepam in the maternity ward: Milk concentrations and clinical effects. Brit J Clin Pharmacol1990; 30:787-793.
9.
9. Price HL. A dynamic concept of the distribution of thiopental in the human body. Anesthesiology1960; 21:40-45.
10.
10. Russo H, Bressolle F, Duboin MP. Pharmacokinetics of high-dose thiopental in pediatric patients with increased intracranial pressure. Ther Drug Monit1997; 19:63-70.
11.
11. Anderson LW, Qvist T et al. Concentrations of thiopentone in mature breast milk and colostrum following an induction dose. Acta Anaesth Scand1987; 31(1):30-32.
12.
12. Dailland P. Cockshott ID et al. Intravenous propofol during cesarean section: Placental transfer, concentrations in breast milk, and neonatal effects. A preliminary study. Anesthesiology1989; 71:827-834.
13.
13. Schmitt JP, Schwoerer D, Diemunsch D, Gauthier-Lafaye J. Passage of propofol in the colostrum. Preliminary data. Ann Fr Anesth Reanim1987; 6:267-268.
14.
14. Campbell GA, Morgan DJ, Kumar K, Crankshaw DP. Extended blood collection period required to define distribution and elimination kinetics of propofol. J Clin Pharmacol1988; 26:187-190.
15.
15. Bromage PR. Neurologic complications of regional anesthesia for obstetrics. In: Schnider SM, Levinson G, eds. In: Anesthesia for Obstetrics. 3rd ed.Baltimore, MD: Williams & Wilkins, 1993:433-433.
16.
16. Sevarino FB, Johnson MD, Lema MJ, Datta S, Osteheimer GW, Naulty JS. The effect of epidural sufentainil on shivering and body temperature in the parturient. Anesth Analg1989; 68:530-533.
17.
17. Hughes, SC. Intraspinal opiates in obstetrics. In: Shnider SM. Levinson G, eds. Anesthesia for Obstetrics. 3rd ed.Baltimore, MD: Williams & Wilkins, 1993:157-157.
18.
18. Khojasteh A, Evans W, Reynolds RD et al: Controlled-release oral morphine sulphate in the treatment of cancer pain with pharmacokinetic correlation. J Clin Oncol1987; 5:56-61.
19.
19. Moolenaar F, Yska JP, Visser J et al. Drastic improvement in the rectal absorption profile of morphine in man. Eur J Clin Pharmacol1985; 29:119-121.
20.
20. Osborne R, Joel S, Trew D et al. Morphine and metabolite behavior after different routes of administration: Demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther1990; 47:12-19.
21.
21. Way WL, Costley EC, Way EL. Respiratory sensitivity of the newborn infant to meperidine and morphine. Clin Pharmacol. Ther1965; 6:454-461.
22.
22. Dick W, Traub E, Moller RM. Epidural morphine in obstetric anesthesia. Obstet Anesth Digest1982; 2:29-31.
23.
23. Terwilliger WG, Hatcher RA. The elimination of morphine and quinine in human milk. Surg Gynecol Obstet. 1934: 58:823-826.
24.
24. Kwit NT, Hatcher RA. Excretion of drugs in milk. Am Dis Child1935; 49:900-904.
25.
25. Feilberg VL, Rosenborg D, Broen Christensen C et al. Excretion of morphine in human breast milk. Acta Anaesthiol Scan1989; 33:426-428.
26.
26. Wittels BK, Scott DT, Sinatra RS. Exogenous opioids in human breast milk and acute neonatal neuro behavior: A preliminary study. Anesthesiology1990; 73:864-869.
27.
27. Robieux I, Koren, G, Vandenberg, H. Schneiderman, J. Morphine excretion in breast milk and resultant exposure of a nursing infant. Clin Toxicol1990; 28:365-370.
28.
28. (Product Information.) Kadian R. Morphine sulfate. Wilmington, DE: Zeneca Pharmaceuticals, 1997.
29.
29. Shnider SM, Way El, Lord MJ. Rate of appearance and disappearance of meperidine in fetal blood after administration of narcotic to the mother. Anesthesiology1966; 27:227-228.
30.
30. Brackbill Y, Kane J, Manniello RL, Abramson D. Obstetric meperidine usage and assessment of neonatal status. Anesthesiology1974; 40:116-120.
31.
31. Hodgkinson R, Bhatt M, Wang CN. Double blind comparison of the neuro behavior of neonates following administration of different doses of meperidine to the mother. Can Anaesth Soc J1978; 25:405-411.
32.
32. Shnider SM, Moya F. Effects of meperidine on the newborn infants. Am J Obstet Gynecol1964; 89:1009-1009.
33.
33. Kuhnert BR, Kuhnert PM, Tu AS, Lin DC. Meperidine and normeperidine levels following meperidine administration during labor. II. Fetus and neonate. Am J Obstet Gynecol1979; 133:909-914.
34.
34. Miller JW, Anderson HH. The effect of N-demethylation on certain pharmacologic actions of morphine, codeine, and meperidine in the mouse. J Pharmacol Exp Ther1954; 112:191-191.
36. Peiker G, Muller B, Ihn W, Noschel H. [Excretion of pethidine in mother's milk]. Zentralbl Gynaekol1980; 102:537-541.
37.
37. Quinn PG, Kuhner BR, Kaine CJ, Syracuse CD. Measurement of meperidine and normeperidine in human breast milk by selected ion monitoring. Biom Envir Mass Spec1986; 13:133-135.
38.
38. Eisele JH, Rogge P. Newborn and maternal fentanyl levels at cesarean section. Anesth Analg1982; 61:179-180.
39.
39. Koehntop DE, Rodman JH, Brundage DM, Hegland MG, Buckley JJ. Pharmacokinetics of fentanyl in neonates. Anesth Analg1986; 65:227-232.
40.
40. Johnson KL, Erickson JP, Holley FO, Scott JC. Fentanyl pharmacokinetics in the pediatric population. Anesthesiology1984; 61: A441-A441.
41.
41. Hughes MA, Glass PSA, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology1992; 76:334-341.
42.
42. Leuschen MP, Wolf LJ, Rayburn WF. Fentanyl excretion in breast milk. Clin Pharm1990; 9:336-337.
43.
43. Gesic AH, Rice LJ, Lipton JM. Alfentanil in colostrum. Anesthesiology1985; 63:A284-A284.
44.
44. Spigset O. Anaesthetic agents and excretion in breast milk. Acta Anaesthesiologica Scandinavica1994; 38:94-103.
45.
45. Nagashima H, Karamanian A, Malovany R et al. Respiratory and circulatory effects of intravenous butorphanol and morphine. Clin Pharmacol Ther1976; 19:738-745.
46.
46. Houde RW, Wallenstein SL, Rogers A, Kaiko RF. Annual report of the analgesic studies section of the Memorial Sloan-Ketering Cancer Center. Washington DC, National Academy of Sciences. Problems of Drug Dependency Committee Proceedings1976; 149-168.
47.
47. Zeisler JA, Garder TD, De Mesquita SA. Lidocaine excretion in breast milk. Drug Intell Clin Pharm1986; 20:691-693.
48.
48. Naulty JS, Ostheimer G, Datta S, Weiss JB. Bupivacaine in breast milk following epidural anesthesia for vaginal delivery. Regional Anesthesia1983; 8(1):44-45.
49.
49. Anderson PO. Drugs and breast feeding. Drug intelligence and clinical pharmacy1977; 11:208-223.
50.
50. Arena JM. Drugs and breast feeding. Clinical Pediatrics1966; 5:472-472.